JPH08217687A - Tyrosinase inhibitor - Google Patents
Tyrosinase inhibitorInfo
- Publication number
- JPH08217687A JPH08217687A JP7067169A JP6716995A JPH08217687A JP H08217687 A JPH08217687 A JP H08217687A JP 7067169 A JP7067169 A JP 7067169A JP 6716995 A JP6716995 A JP 6716995A JP H08217687 A JPH08217687 A JP H08217687A
- Authority
- JP
- Japan
- Prior art keywords
- chestnut
- japanese chestnut
- leaf
- extract
- added
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は他の目的の医薬品等とし
て多年内用され、安全性が保証された植物の抽出物を用
いて、チロシナーゼの活性を抑制して、皮膚の美白に有
効なチロシナーゼ阻害剤に関する。BACKGROUND OF THE INVENTION The present invention has been used for many years as a drug for other purposes, etc., and uses a plant extract of which the safety is assured to suppress the activity of tyrosinase and to effectively whiten the skin. It relates to tyrosinase inhibitors.
【0002】[0002]
【従来の技術】栗は北海道西南部から九州及び朝鮮半島
に分布する落葉高木で堅実は広く食用とされ、その葉は
栗葉と、またそのいがは栗毛毬と呼ばれ、うるしかぶ
れ、あせも、やけどなどに外用される。2. Description of the Related Art Chestnuts are deciduous trees that are distributed from southwestern Hokkaido to Kyushu and the Korean Peninsula and are widely used for food. Their leaves are called chestnut leaves, and their leaves are known as chestnut palms. Used externally for burns, etc.
【0003】[0003]
【発明が解決しようとする課題】本発明の目的は、皮膚
に適用して安全であると共に、チロシナーゼ阻害作用が
強い原料を提供することである。チロシナーゼは、皮膚
に存在する酵素で、その働きはチロシンからメラニンを
生成し、皮膚の色を黒色化する。古くより色の白いのは
七難隠すといわれ、多くの女性の願望であった。SUMMARY OF THE INVENTION An object of the present invention is to provide a raw material which is safe when applied to the skin and has a strong tyrosinase inhibitory action. Tyrosinase is an enzyme that is present in the skin, and its function produces melanin from tyrosine, which darkens the skin color. It is said that the white one, which has been colored since ancient times, is said to hide the seven difficulties, and was a desire of many women.
【0004】[0004]
【課題を解決する手段】本発明者らは、前記の課題を解
決するため、すでに多年にわたって食用に供され、人体
に対する安全性が確認されている植物をスクリーニング
して調べ、チロシナーゼ阻害剤として利用価値のあるも
のを検討した。その結果、栗の葉、栗のいがが非常にチ
ロシナーゼ阻害作用が強い原料であることを見出した。[Means for Solving the Problems] In order to solve the above-mentioned problems, the present inventors screened and examined plants that had been used for food for many years and confirmed to be safe for humans, and used as tyrosinase inhibitors. Considered something of value. As a result, they have found that chestnut leaves and chestnut gall are raw materials having a very strong tyrosinase inhibitory action.
【0005】すなわち、本発明は、栗の葉、栗のいがの
溶媒抽出物を含むチロシナーゼ阻害剤である。That is, the present invention is a tyrosinase inhibitor containing a solvent extract of chestnut leaves and chestnut potato.
【0006】栗の葉、栗のいがの利用方法としては、水
或いは親水性有機溶媒例えば、エタノール、メタノー
ル、アセトン等で抽出する。しかしながら、化粧品原料
の抽出であるから、水或いはエタノール或いはこれの混
合溶媒での抽出が好ましいのは当然である。また、場合
によっては、グリセリン、1,3ブチレングリコール、
プロピレングリコール等の多価アルコール又は多価アル
コールと水の混液も抽出に利用できる。またさらに凍結
乾燥して粉体として利用することも利用方法によっては
有効である。The chestnut leaves and chestnut mushrooms can be used by extraction with water or a hydrophilic organic solvent such as ethanol, methanol or acetone. However, it is natural that extraction with water, ethanol, or a mixed solvent thereof is preferable since it is extraction of cosmetic raw materials. In some cases, glycerin, 1,3 butylene glycol,
A polyhydric alcohol such as propylene glycol or a mixed liquid of polyhydric alcohol and water can also be used for extraction. Further, freeze-drying and using it as powder is also effective depending on the method of use.
【0007】この物質を他の化粧品原料例えばスクワラ
ン、ホホバ油等の液状油、ミツロウ、セチルアルコール
等の固体油、各種の活性剤、グリセリン、1,3ブチレ
ングリコール等の保湿剤や各種薬剤等を添加してさまざ
まな剤形の化粧料を調整することができる。例えばロー
ション、クリーム、乳液、パック等で目的に応じて利用
形態を考えればよい。[0007] This substance is used as other cosmetic raw materials such as liquid oils such as squalane and jojoba oil, solid oils such as beeswax and cetyl alcohol, various activators, humectants such as glycerin and 1,3 butylene glycol, and various drugs. It can be added to adjust various dosage forms of cosmetics. For example, a lotion, a cream, a milky lotion, a pack, or the like may be used depending on the purpose.
【0008】[0008]
【実施例】以下に実際の利用方法である実施例を記載す
るが、本発明はこの実施例によって何ら限定されるもの
ではない。本発明で使用した栗の葉、栗のいがの抽出物
の実施例を次に示す。EXAMPLE An example of an actual usage will be described below, but the present invention is not limited to this example. Examples of chestnut leaves and chestnut mushroom extracts used in the present invention are shown below.
【0009】実施例1 栗の葉10gに精製水300mlを加えて3時間加熱す
る。これを濾過後凍結乾燥した。Example 1 To 10 g of chestnut leaves, 300 ml of purified water was added and heated for 3 hours. This was filtered and freeze-dried.
【0010】実施例2 栗いが10gに精製水300mlを加えて3時間加熱す
る。これを濾過後凍結乾燥した。Example 2 To 10 g of chestnut, 300 ml of purified water was added and heated for 3 hours. This was filtered and freeze-dried.
【0011】実施例3 栗いが30gにエタノール300mlを加えて時々撹拌
しつつ5日間放置した。これをエバポレート濾過後凍結
乾燥した。Example 3 300 g of ethanol was added to 30 g of chestnut and left for 5 days with occasional stirring. This was evaporated and lyophilized.
【0012】実施例4 栗いが(乾燥品)を10gに精製水300mlを加えて
3時間加熱する。これを濾過後凍結乾燥した。Example 4 To 10 g of chestnut (dry product), 300 ml of purified water was added and heated for 3 hours. This was filtered and freeze-dried.
【0013】 実施例5 ローション オリーブ油 0.5 実施例1 0.5 ホリオキシエチレン(20E.0)ソルヒタンモノステアレート 2.0 ホリオキシエチレン(60E.0)硬化ヒマシ油 2.0 エタノール 10.0 1.0%ヒアルロン酸ナトリウム水溶液 5.0 精製水 80.0Example 5 Lotion Olive Oil 0.5 Example 1 0.5 Folioxyethylene (20E.0) Solhitane Monostearate 2.0 Folioxyethylene (60E.0) Hydrogenated Castor Oil 2.0 Ethanol 10. 0 1.0% sodium hyaluronate aqueous solution 5.0 Purified water 80.0
【0014】 実施例6 クリーム A スクワラン 20.0 オリーブ油 2.0 ミンク油 1.0 ホホバ油 5.0 ミツロウ 5.0 セトステアリルアルコール 2.0 グリセリンモノステアレート 1.0 ソルビタンモノステアレート 2.0 実施例2 1.0 B 精製水 47.9 ホリオキシエチレン(20E.0)ソルヒタンモノステアレート 2.0 ホリオキシエチレン(60E.0)硬化ヒマシ油 1.0 グリセリン 5.0 1.0%ヒアルロン酸ナトリウム水溶液 5.0 パラオキシ安息香酸メチル 0.1 AとBをそれぞれ計量し、70℃まで加温し、BにAを
撹拌しつつ徐々に加えたのち、ゆっくり撹拌しつつ30
℃まで冷却した。Example 6 Cream A Squalane 20.0 Olive Oil 2.0 Mink Oil 1.0 Jojoba Oil 5.0 Beeswax 5.0 Cetostearyl Alcohol 2.0 Glycerin Monostearate 1.0 Sorbitan Monostearate 2.0 Example 2 1.0 B Purified water 47.9 Folioxyethylene (20E.0) solhitanium monostearate 2.0 Folioxyethylene (60E.0) hydrogenated castor oil 1.0 Glycerin 5.0 1.0% Aqueous sodium hyaluronate solution 5.0 Methyl paraoxybenzoate 0.1 Weigh A and B respectively, warm to 70 ° C., slowly add A to B with stirring, then slowly agitate with 30
Cooled to ° C.
【0015】実施例−7は実施例−5の実施例1の抽出
物を実施例3の抽出物に変え作成したものExample-7 was prepared by replacing the extract of Example-1 of Example-5 with the extract of Example-3.
【0016】実施例−8は実施例−6の実施例2の抽出
物を実施例4の抽出物に変え作成したものExample-8 was prepared by replacing the extract of Example-2 of Example-6 with the extract of Example-4.
【0017】チロシナーゼ活性阻害試験 (試験方法)30mMリン酸緩衝液(pH6.8)0.
9ml、1.66mMチロシン(Tyrosine)溶
液1.0ml、前記実施例(凍結乾燥品)の0.1wt
/v%水溶液(溶解しにくい場合はエタノールを加えて
溶解したのち精製水を加えて、エバポレートし、エタノ
ールを除去したのち、0.1wt/v%になるように調
製した)1.0mlをスクリューバイアルにとり、37
℃恒温水槽中で5分以上加温した。チロシナーゼ溶液
(Sigma社製、マッシユルーム由来、914ユニッ
ト/ml)0.1mlを加え、37℃恒温水槽中で保温
し、10分後に475nmで吸光度を測定した。対照と
して、上記試料液のかわりに純水を加え同様に測定し
た。この試験では試料の終濃度は0.033%となる。 (計算式) チロシナーゼ活性阻害率(%)={B−(A−P)}/
B×100 但し A:試料検体の吸光度 B:対照の吸光度 P:試料検体の着色による吸光度(3倍希釈)Tyrosinase activity inhibition test (test method) 30 mM phosphate buffer (pH 6.8)
9 ml, 1.66 mM Tyrosine solution 1.0 ml, 0.1 wt of the above-mentioned example (lyophilized product)
/ V% aqueous solution (if it is difficult to dissolve, add ethanol to dissolve it, and then add purified water to evaporate and remove ethanol to prepare 0.1 wt / v%) 1.0 ml screw 37 for vial
It was heated in a constant temperature water bath at ℃ for 5 minutes or more. 0.1 ml of a tyrosinase solution (manufactured by Sigma, derived from Massroom, 914 units / ml) was added, and the mixture was kept warm in a 37 ° C. constant temperature water bath, and after 10 minutes, the absorbance was measured at 475 nm. As a control, pure water was added instead of the sample solution, and the measurement was performed in the same manner. In this test, the final concentration of the sample is 0.033%. (Calculation formula) Tyrosinase activity inhibition rate (%) = {B- (AP)} /
B × 100 However, A: Absorbance of sample specimen B: Absorbance of control P: Absorbance due to coloring of sample specimen (3-fold dilution)
【0018】[0018]
【表1】 [Table 1]
【0019】使用テスト 女性6名づつの顔面を左右に分け、一方を実施例、もう
一方を比較例として毎日、1回以上使用してもらって、
3月後、アンケートした。なお、比較例は実施例5、6
よりそれぞれ実施例1、2を水にかえたものである。
(比較例1,2) なお、12名を2班にわけ、下記の試料を使って実験し
た。 Usage test Each of the six female faces was divided into left and right sides, one of which was used as an example and the other of which was used as a comparative example once or more daily.
After three months, I did a questionnaire. The comparative examples are Examples 5 and 6.
More specifically, Examples 1 and 2 are replaced with water.
(Comparative Examples 1 and 2) In addition, 12 people were divided into 2 groups, and experiments were conducted using the following samples.
【0020】判定基準は以下のようでアンケートの結果
をまとめたのが以下の表である。 実施例の方が非常によい 3 実施例の方がかなりよい 2 実施例の方がややよい 1 差がない 0 比較例の方がややよい −1 比較例の方がかなりよい −2 比較例の方が非常によい −3The criteria are as follows, and the results of the questionnaire are summarized in the table below. Example is much better 3 Example is much better 2 Example is slightly better 1 No difference 0 Comparative example is slightly better -1 Comparative example is much better -2 Comparative example Is much better -3
【0021】 [0021]
【0022】[0022]
【効果】本発明の栗の葉、栗のいがの溶媒抽出物、或い
はそれを配合したクリーム、ローション等のチロシナー
ゼ活性阻害剤は優れたチロシナーゼ活性阻害を示し、美
白効果を有する。また、これらは長年にわたって利用さ
れてきており、その安全性については保証されている。[Effect] The tyrosinase activity inhibitor of the present invention such as chestnut leaves, chestnut mushroom solvent extract, or creams and lotions containing the same extract shows excellent tyrosinase activity inhibition and has a whitening effect. Moreover, these have been used for many years, and their safety is guaranteed.
Claims (1)
ロシナーゼ阻害剤1. A tyrosinase inhibitor containing a solvent extract of chestnut leaves and chestnut mushrooms.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP06716995A JP3792745B2 (en) | 1995-02-15 | 1995-02-15 | Tyrosinase inhibitor |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP06716995A JP3792745B2 (en) | 1995-02-15 | 1995-02-15 | Tyrosinase inhibitor |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH08217687A true JPH08217687A (en) | 1996-08-27 |
JP3792745B2 JP3792745B2 (en) | 2006-07-05 |
Family
ID=13337134
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP06716995A Expired - Fee Related JP3792745B2 (en) | 1995-02-15 | 1995-02-15 | Tyrosinase inhibitor |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3792745B2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005350422A (en) * | 2004-06-14 | 2005-12-22 | Sanei Seiyaku Kk | Active oxygen scavenger |
JP2007522161A (en) * | 2004-02-13 | 2007-08-09 | コグニス・フランス・ソシエテ・パール・アクシオン・サンプリフィエ | Cosmetic composition containing castanea sativa leaf extract |
JP2012530700A (en) * | 2009-06-18 | 2012-12-06 | 株式会社アモーレパシフィック | Cosmetic composition containing chestnut skin extract |
KR101304677B1 (en) * | 2012-05-08 | 2013-09-06 | 신유현 | A chestnut bur extracts and a cosmetic composition containing the chestnut bur extracts as an active ingredient |
-
1995
- 1995-02-15 JP JP06716995A patent/JP3792745B2/en not_active Expired - Fee Related
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007522161A (en) * | 2004-02-13 | 2007-08-09 | コグニス・フランス・ソシエテ・パール・アクシオン・サンプリフィエ | Cosmetic composition containing castanea sativa leaf extract |
US8067044B2 (en) | 2004-02-13 | 2011-11-29 | Cognis France S.A.S. | Cosmetic compositions containing an extract of leaves of the Castanea sativa plant and cosmetic treatments |
JP2005350422A (en) * | 2004-06-14 | 2005-12-22 | Sanei Seiyaku Kk | Active oxygen scavenger |
JP2012530700A (en) * | 2009-06-18 | 2012-12-06 | 株式会社アモーレパシフィック | Cosmetic composition containing chestnut skin extract |
KR101304677B1 (en) * | 2012-05-08 | 2013-09-06 | 신유현 | A chestnut bur extracts and a cosmetic composition containing the chestnut bur extracts as an active ingredient |
Also Published As
Publication number | Publication date |
---|---|
JP3792745B2 (en) | 2006-07-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH0977636A (en) | Beautifying and whitening cosmetic | |
JPH09291011A (en) | Composition suitable for eternal use | |
JPH07101871A (en) | Promoter for synthesis of hyaluronic acid in living body | |
JPH07277939A (en) | Skin external preparation | |
JPH08119869A (en) | Active oxygen suppressor | |
JPH1025238A (en) | Preparation for external use for skin | |
JPH07126146A (en) | Sin external preparation | |
JPH05306214A (en) | Cosmetic | |
JPH08283143A (en) | Skin preparation for external use | |
JPH06336422A (en) | External agent for skin | |
JP3235922B2 (en) | Cosmetics | |
JPH069422A (en) | Promoter for biosynthesis of hyaluronic acid | |
JPH10114670A (en) | Composition suitable for external use | |
JPH08217687A (en) | Tyrosinase inhibitor | |
JPH1029927A (en) | Antiaging agent | |
JP3507635B2 (en) | Composition suitable for external use | |
JP3496967B2 (en) | Antiplasmin agent | |
JP3667376B2 (en) | Hyaluronidase inhibitor | |
JP3235919B2 (en) | Cosmetics | |
JP3885243B2 (en) | Skin cosmetics | |
JPH0687731A (en) | Cosmetic | |
JPH09315930A (en) | Cosmetic material for skin | |
JP3390549B2 (en) | Skin cosmetics | |
JPH05155750A (en) | Cosmetic | |
JP3408339B2 (en) | Cosmetics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20050113 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20050208 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050214 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20060207 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060209 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20060404 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20060406 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120414 Year of fee payment: 6 |
|
LAPS | Cancellation because of no payment of annual fees |